More importantly, higher GRIM-19 protein levels in tumor tissues could distinguish a subset of patients with increased risk of poor overall survival, demonstrating the clinical significance of GRIM-19 loss in the clinical outcomes of GC patients. Here, NDUFA13 is linked to gastric cancer.